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Abstract: This study applies a cluster analysis to identify typical physical activity (PA) and sedentary
behaviour (SB) patterns in people with chronic obstructive pulmonary disease (COPD) before starting
pulmonary rehabilitation (PR). We implemented an observational design which assessed baseline
data of objectively measured PA and SB from the STAR (Stay Active after Rehabilitation) study. A
total of 355 persons wore an accelerometer (Actigraph wGT3X) for seven days before the start of their
PR. Sociodemographic and disease-related parameters were assessed at the start of PR. We applied
cluster analysis and compared clusters applying univariate variance analyses. Data was available
for 326 persons (31.6% women; age ø = 58 years). Cluster analysis revealed four movement clusters
with distinct PA and SB patterns: Sedentary non-movers (28.5%), sedentary occasional movers
(41.7%), sedentary movers (19.6%), and sedentary exercisers (10.1%). The four clusters displayed
varying levels of moderate PA before rehabilitation (Ø daily min: 9; 28; 38; 70). Notably, all four
clusters displayed considerably long average sedentary time per day (Ø daily minutes: 644; 561; 490;
446). The clusters differed significantly in disease-related parameters of GOLD severity, FEV1, CAT,
and 6-Min-Walk-Test. In addition to PA promotion, PR programs should consider the reduction of
sedentary behaviour as a valuable goal.
Keywords: chronic obstructive pulmonary disease; exercise; motor activity; lung diseases;
classificatory approach
1. Introduction
Regular physical activity (PA) is proven to help treat noncommunicable diseases (NCDs) [1].
Accordingly, the World Health Organization (WHO) [2] recommends adults with NCD perform at
least 150 min of moderate intense aerobic PA per week or 75 min of vigorous intensity aerobic PA for
improved health. For people with chronic obstructive pulmonary disease (COPD) engaging in the
recommended moderate-to-vigorous physical activities (MVPA) results in improved muscle function,
increases in exercise capacity, decreased mood disturbance, reduced symptom burden, and improved
cardiovascular function [3].
Nevertheless, health-related movement behaviour is multi-layered. It not only includes MVPA
but a wide variety of PA in different intensities spanning from running, walking or standing, as well
as sedentary behaviour (SB) [4]. For people with COPD, all aspects of movement behaviour are
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significant and are associated with several health consequences. PA levels, including PA in light,
moderate and vigorous intensities positively influence various health outcomes, including reduced
risks of COPD exacerbations, reduced risk of mortality, and improved quality of life [5]. Light intensity
PA (e.g., slow walking) seems to be beneficial, which among other benefits leads to reduced risk of
COPD hospitalizations [6]. In addition to low levels of PA, SB is now considered a separate risk
factor. After adjusting for MVPA levels, sedentary time is a strong predictor of mortality in the general
population [7] and in people with COPD [8]. For people with COPD, high sedentary time is associated
with poor overall and mental health, unhealthy aging, and overnight hospital stays [9].
Looking at persons with COPD at a group level, average PA levels are low and sitting time
is high [10–12]. Nevertheless, the heterogeneity in movement behaviours between individuals is
remarkably high. Evenson et al. [13] showed large differences in MVPA and sitting time in a sample
of 4510 healthy adults. In people with COPD, however, the dominance of means-based analysis in
previous research [10–12] has yet failed to reveal this heterogeneity in most studies.
Classification approaches (e.g., cluster analysis) are superior to means-based analysis; they help
to generate a detailed understanding of movement behaviours by exploring heterogeneity and aiming
to find distinct PA and sedentary patterns. In 2017, Mesquita et al. [14] initially applied cluster analysis
techniques to movement behaviour in people with COPD. The authors showed that cluster analysis
is a powerful classification tool for this clinical population as they identified five distinct movement
clusters with significant differences in daily PA within different intensity levels. Their results illustrate
that, even if the average PA in people with COPD might be low, specific subgroups may be sufficiently
active to meet guidelines. The promotion of physical activity is a central goal of PR [3]; nevertheless,
it is unclear whether this goal is equally important for all persons with COPD and how the initial
conditions of rehabilitants differ with regard to physical activity levels. In people with COPD before
starting a PR, a classification approach which considers all health-relevant intensity ranges of PA and
SB is still pending.
Using baseline data from the STAR (Stay Active after Rehabilitation) study, this study
quantified health-related PA and SB in patients with COPD, to identify typical movement clusters
based on those measures. Secondly, we compared clusters with regard to demographic and
disease-related characteristics.
2. Methods
This study uses cross-sectional data from the baseline assessment of the STAR study participants
(Clinical Trials Registration Number Clinicaltrials.gov, ID: NCT02966561) [15]. The STAR study
protocol was approved by the independent Research Ethics Committee of the Medical Faculty of
Friedrich-Alexander University Erlangen-Nürnberg, Germany in 2015 (Re.-No. 321_15B).
2.1. Study Population
This study includes subjects who had been referred by their doctor to a PR in the inpatient
pulmonary rehabilitation clinic Bad Reichenhall (Bavaria, Germany) with the following inclusion
criteria: Physician-confirmed diagnosis of COPD (international classification code: J44.- at all 2011
GOLD classifications A–D); age ≥ 18 years. We excluded persons in case of severe comorbidities or
inability to speak German. The PR was paid for by the German pension insurance fund for roughly
90% of all participants. Therefore, most of the patients with COPD were employed and younger
than 65 years. The rehabilitation team at clinic in Bad Reichenhall contacted a total of 797 persons
approximately one month before their planned three-week inpatient stay in the rehabilitation clinic,
asked via telephone whether they would be willing to voluntarily join the study. Of these, 418 patients
(52.4%) provided informed consent to study participation and subsequently received a plain language
statement, a questionnaire and a hip-worn accelerometer (ActiGraph wGT3X-BT, Pensacola, FL, USA).
A total of 92 participants were excluded from the analysis due to the following reasons: Retraction
of the initial COPD diagnosis of the family doctor by the lung specialist in the rehabilitation clinic
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(n = 62), persons not attending PR (n = 1), retrospective withdrawal of consent to data use (n = 1),
unreturned Actigraph device or insufficient wear time (n = 28). This led to an overall sample of 326
patients included in the activity analysis (see Figure 1 and Table 1).
Figure 1. Flow chart for the analysis.
Table 1. Characteristics of the whole sample.
n 326
Age (years) 58.2 ± 5.6
Sex (% male) 67.8%
Height (cm) 170 ± 9.2
Weight (kg) 80.2 ± 20.9
BMI (kg/m2) 27.4 ± 6.5
FEV1 (%) 53.7 ± 18.2
GOLD Severity Classification 1/2/3/4 (%) 9.3/44.4/38.0/8.3
GOLD Classification A/B/C/D (%) 1.7/44.2/0/53.6
COPD Assessment Test (CAT Score) 23.37 ± 6.71
Number of Comorbidities 4.48 ± 2.58
Percentage of Current Smokers 45.8%
Employed 75.3%
Sedentary Behaviour (min/day) 559.4 ± 92.9
Moderate-to-Vigorous Physical Activity (min/week) 204.3 ± 160.9
Number of Steps (per day) 5803 ± 3051
2.2. Assessments
2.2.1. Physical Activity and Sedentary Behaviour
Daily PA and SB were objectively assessed using the validated tri-axial Actigraph wGT3X-BT
accelerometer [16,17] which is explicitly recommended for subjects with COPD [18,19]. Participants
were instructed to wear the activity monitor on the right hip for seven days during waking hours and
reminded to take off the device only during water-based activities [17,20]. Wear-time and periods of
non-wear time, e.g., taking a shower, were logged at the end of each day in the activity diary provided.
Participants were sent the activity monitors two weeks before their rehabilitation was scheduled and
asked to wear the device for the seven-day measurement under free-living conditions in their home
before entering the rehabilitation clinic.
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2.2.2. Secondary Outcomes
All secondary outcome measures were completed upon arrival at the inpatient pulmonary
rehabilitation clinic Bad Reichenhall. Secondary outcome measures included the COPD assessment
test (CAT) [21]. The CAT is a short, simple questionnaire consisting of eight statements that measure
disease impact on health status. Scoring for the test ranges from 0–40 with higher scores denoting
higher levels of disease impact. Scores < 10 indicate a low impact, 10–20 medium, 21–30 high, and
>30 a very high impact level. Patients’ functional capacity was assessed with one 6-minute walk test
(6MWT). The 6MWT is a valid, responsive and reliable test that is considered representative of the
overall functional status for people with COPD [22]. Finally, airflow limitation was measured in the
clinic using post-bronchodilator FEV1/FVC to classify patients into the four GOLD stages; 1, mild; 2,
moderate; 3, severe; and 4, very severe [23]. Furthermore, GOLD classification A/B/C/D was extracted
from the information on the individuals’ exacerbations, clinic stays, and CAT scores [24]. Finally,
the number of comorbidities was based on a standardised list of 31 standardized diseases and eight
free specifications filled out by the responsible physician.
2.3. Assessments
2.3.1. Processing of Accelerometer Data
We used the ActiLife v6.13.3 software to transform the raw accelerometer output into cumulated
activity scores attributable to different intensity categories. We thereby relied on the Freedson
algorithm [25] which defines fixed count values in accordance with established metabolic equivalent
tasks (MET) cut-offs: Sedentary behaviour with activity counts of 0 to ≤100 per minute, light PA
with activity counts >100 to 1951, moderate PA with activity counts >1952 to 5724 (MPA), and
vigorous physical activity (VPA) with activity counts > 5725 [20,26]. In order to ensure differentiation
between very light forms of PA (1.5 MET < x < 2 MET) and light forms of PA (2 MET ≤ x < 3 MET),
the Freedson cutpoints were supplemented by the additional cutpoint of 929 points proposed by Cain
and Geremia [27]. According to the methodological standards proposed by Byrom and Rowe [20].
Actigraphs were initialised at a frequency of 100 Hz and downloaded using 15 second epochs. A
measurement was considered valid if the patients had a wear-time of ≥10 h per day for at least five of
the seven measuring days with no requirements for specific numbers of weekend or week days [20].
For valid measurements, all available measuring days with a wear-time of ≥10 h were taken into
account in the analysis.
2.3.2. Determining the Number of Clusters
To determine the number of clusters, we firstly explored the time participants spent in the different
intensity categories. Across the entire sample, participants scarcely recorded activity in the vigorous
intensity range; the average daily activity time in vigorous PA was less than one minute. Against the
background of the volume of VPA near to zero, we heavily questioned the suitability of VPA as an
indicator for the identification of clusters. Our assumption was confirmed by principal component
analysis (PCA) which revealed comparably low anti-image correlations for the VPA parameter. Hence,
we have not included the parameter VPA for the cluster formation. We relied on the cluster formation
process of four z-standardized activity indicators: Average daily sedentary time, and PA in very light,
light and moderate intensity (see Supplementary Table S1).
Hierarchical cluster analysis was applied to determine the final number of clusters. We relied on
squared Euclidean distance metric and the ward algorithm as a conservative merging procedure [28].
In the scientific literature, there is no formal gold standard of how to assign the number of
clusters, instead a combination of statistical and content-related arguments should be considered [28].
Accordingly, we first inspected the Scree plot (see Supplementary Figure S1) which visualises the
increase in explained variance while reducing the number of hypothetical clusters. In addition to
this subjective decision procedure, we made use of two stopping rules which have achieved the best
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results in an extensive simulation study [29] comparing a total of 30 indicators: The Calinski and
Harabasz [30] criterion and the Je(2)/Je(1) criterion by Duda and Hart [31].
2.3.3. Comparison of the Different Clusters
After the cluster formation process, we extracted descriptive statistics for the characterization of
different activity clusters including time spent in SB, very light PA, light PA, moderate PA, vigorous PA
and, finally, the total number of steps per day.
Afterwards, the different clusters were compared with respect to the following information
from the baseline assessment: Gender (male vs. female), age (in years), respiratory function (via
FEV1 which forms the basis for the classification of disease severity), body composition (body mass
index (BMI; in kg/m2), extracted objectively from measured height and weight), exercise capacity
(six-minute-walking-test (meters)), and disease impact (COPD Assessment Test, CAT, range: 1–40).
In addition, we performed an activity bout analysis which quantifies time spent continuously in specific
intensity areas (similar as to McVeigh et al. [32]).
All analyses were run in the software R, version 3.4.3 using the package NbClust [33]. For the
cluster comparison, we calculated univariate ANOVA with the effect size η2. If necessary, TukeyHSD
post-hoc analyses served to attribute an overall effect to concrete cluster constellation(s). When the
assumption of variance homogeneity was violated, we applied Welch’s ANOVA and the Dunnett
post-hoc test. For the dichotomous variable of gender, we used the chi-square (χ2) test to inspect
substantial deviations from equal distribution across the clusters. The significance level was set at
p < 0.05.
3. Results
3.1. Number of Different Movement Behaviour Clusters
The scree plot (see Supplementary Figure S1) suggested that the activity indicators can
be adequately described by three clusters. The Calinski–Harabasz criterion favours three
clusters (CHmax = 279.44) whereas the Duda–Hart criterion suggest an extraction of four clusters
(DHmax = 0.688). To clarify these ambiguous recommendations, we undertook a deeper comparison
of both solutions to reach a final decision on the number of clusters. The analysis revealed that the
three and four cluster options were nested within each other, with the slight distinction that the four
cluster solution still differentiates within the most active cluster at the top of the activity scale. Due to
this finer extraction, we present results from the four cluster solution.
Overall, the clusters explained between 50% and 76% of the variance in the four indicators, i.e.,
sedentary behaviour, F(3, 112.8) = 94.5, p < 0.001, η2 = 0.501, very light PA, F(3, 106.6) = 123.8, p < 0.001,
η2 = 0.533, light PA, F(3, 106.7) = 265.0, p < 0.001, η2 = 0.760 and moderate PA, F(3, 102.9) = 193.3,
p < 0.001, η2 = 0.600. Importantly, there was no significant difference in the accelerometer wear time
between the different clusters, F(3, 322) = 2.46, p = 0.063.
3.2. Characterisation of the Clusters: Physical Activity and Sedentary Behaviour
The cluster formation process resulted in four distinct clusters of different size. Cluster one
(sedentary non-movers) comprised 93 individuals (28.5%) who were comparably inactive (e.g., an
average of 644.3 ± 76.0 min sedentary behaviour per day) and in most cases (94.6%) did not meet the
WHO guidelines for PA [2]. With a total of 136 persons, cluster two (sedentary occasional movers)
was the largest cluster (41.7%) and somewhat more active than the first cluster (e.g., an average
of 561.5 ± 59.9 min sedentary behaviour per day). Cluster three (sedentary movers) included 64
individuals (19.6%) who were comparably active in relation to 70.2% of patients made up of clusters
one and two. They performed an average of 38.9 ± 12.0 min MVPA per day. Correspondingly, the large
majority of this cluster (95.3%) fulfilled the aforementioned activity guidelines. Finally, cluster four
constitutes the smallest (10.1%) but by far most active cluster. The 33 members had a daily sedentary
J. Clin. Med. 2019, 8, 1346 6 of 16
time of 445.6 ± 68.6 min, but more importantly, they performed an average of more than one hour
MVPA per day (71.4 ± 25.4 min). According to the cluster designations of Mesquita et al. [14] we have
named cluster 3 sedentary movers, and cluster 4 sedentary exercisers. Overall, there was a progressive
increase for activity indicators across the four clusters (see Table 2 and Figure 2).
Figure 2. Daily time of the four clusters in sedentary time and in activities of low light, high light and
moderate intensity.
3.3. Characterisation of the Clusters: Other Parameters
There was a main effect for the age variable, F(3, 322) = 2.70, p = 0.046, η2 = 0.025. Post-hoc
analyses revealed that cluster one was significantly older than cluster three (d = 0.43). Gender was
equally distributed across the four clusters, χ2(3) = 2.70, p = 0.74. Likewise, there were no differences
for BMI between the clusters, F(3, 312) = 0.012, p = 0.998.
Furthermore, the ANOVA demonstrated that activity clustering is also closely related to functional
parameters (see Table 2). For instance, lung function differed significantly across the sample, F(3,
113.0) = 25.61, p < 0.001, η2 = 0.175. All clusters differed significantly from each other (except the
clusters three and four), whereby the FEV1 value was lowest in cluster one and highest in cluster
four. In accordance with the fact that the FEV1 parameter forms the basis for the classification of
disease severity, there was a similar pattern for GOLD stage classifications 1–4, χ2(9) = 49.08, p < 0.001,
Cramérs V = 0.226. In contrast, no differences could be registered for GOLD classification A/B/C/D,
χ2(6) = 5.81, p = 0.45, and the number of comorbidities, F(3, 322) = 1.05, p = 0.371. However, the four
clusters also differed significantly with regard to the CAT Score, F(3, 118.7) = 12.78, p = 0.998, η2 = 0.087.
Specifically, the least active cluster perceived a higher impact of disease than the three other clusters.
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Table 2. Characteristics of the four clusters.
Cluster 1
(Sedentary Non-Movers)
Cluster 2
(Sedentary occasional Movers)
Cluster 3 (Sedentary
Movers)
Cluster 4 (Sedentary
Exercisers) df F p Effect Size η
2
General Characteristics
N 93 136 64 33
% 28.5% 41.7% 19.6% 10.1%
Age (years) 59.5 (6.1) 58.0 (6.0) 57.1 (4.1) 57.4 (4.5) 3, 322 2.70 0.046 0.025
Sex (% male) a 72.0 68.1 64.1 65.6 3 1.24 a 0.744 a -
BMI (kg/m2) 27.39 (7.27) 27.44 (6.68) 27.40 (5.81) 27.19 (5.14) 3, 312 0.012 0.998 -
FEV1 (%) 43.10 (13.81) 54.25 (17.95) 61.82 (17.47) 64.89 (16.71) 3, 113.0 25.61 <0.001 0.175
GOLD 1/2/3/4 (%) a 0/31.8/50.0/18.2 7.7/46.9/39.2/6.2 19.4/50.0/29.0/1.6 21.2/57.6/18.2/3.0 9 49.082 a <0.001 V = 0.226 a
GOLD A/B/C/D (%) a 0/37.6/0/62.4 1.6/49.2/0/49.2 1.8/49.1/0/49.1 3.3/46.7/0/50.0 6 5.81 a 0.445 -
Comorbidities 4.37 (2.77) 4.29 (2.47) 4.92 (2.60) 4.76 (2.42) 3, 322 1.05 0.371 -
COPD Assessment Test 26.37 (5.84) 22.34 (6.74) 22.63 (7.37) 20.59 (4.68) 3, 118.7 12.76 <0.001 0.087
6-Min-Walk-Test (in m) 386.1 (103.8) 458.7 (97.6) 496.7 (71.5) 503.3 (79.1) 3, 298 22.23 <0.001 0.183
Physical Activity and Sedentary Behaviour (min/day)
Very Light PA 102.97 (26.78) 147.82 (32.29) 191.61 (35.20) 210.15 (55.3) 3, 106.6 123.8 <0.001 0.533
Light PA 25.00 (10.89) 44.81 (10.95) 70.22 (12.46) 93.92 (18.55) 3, 106.7 265.0 <0.001 0.760
Moderate PA 9.23 (6.09) 27.60 (16.12) 38.49 (11.88) 69.76 (23.38) 3, 102.9 193.3 <0.001 0.600
Vigorous PA 0.13 (0.21) 0.34 (1.50) 0.36 (0.88) 1.64 (3.76) 3, 94.4 3.94 0.011 0.067
Steps (per day) 2749 (1064) 5649 (1826) 7866 (1786) 11045 (2621) 3, 106.1 243.3 <0.001 0.678
Overall Sedentary Time 644.33 (76.02) 561.46 (59.93) 490.22 (60.43) 445.58 (68.54) 3, 112.8 94.5 <0.001 0.501
Wear Time (min/day) 780.1 (87.2) 781.4 (73.7) 793.1 (82.2) 819.7 (68.0) 3, 322 2.46 0.063 -
Note: Mean values (and standard deviation in brackets) of the different variables; a Due to the dichotomous character of the variables gender and GOLD classification, we used here the
χ2-test with the effect size Cramer’s V.r clusters in sedentary time and in activities of very light, light, and moderate intensity.
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3.4. Activity Bout Analysis
In accordance with the analysis of overall activity time, most bouts were identified as SB. Figure 3
displays the activity bout analysis for all four clusters. The distribution of different bout length
categories was broadly comparable across the four clusters. However, the most active clusters (clusters
3 and 4) showed a trivial number of very long (≥60 min) sedentary periods (1.8% and 1.6%) whereas
the most inactive clusters spent more than 150 min per day in these segments. The differences in very
light activity bouts were even more apparent. In cluster one, time spent in very light PA bouts was
negligible compared to their sedentary bouts. Clusters three and four, in contrast, spent a substantial
amount of time in these light PA blocks of under five minutes (13.2% and 15.3%) or five to ten min
(10.2% and 12.7%). In cluster four, notably, the absolute time in 5–10 min bouts was even higher for
very light PA than for SB (11.2%).
Figure 3. Physical activity and sedentary bout analysis for all four clusters.
Clusters three and four showed only few continuous activity periods of moderate or vigorous
intensity. Nevertheless, members of clusters three (M = 41 min; 1.9%) and four (M = 75 min; 3.4%)
demonstrated substantially more short bouts (<5 min) of moderate intensity than their counterparts in
the cluster one (M = 10 min; 0.3%).
4. Discussion
This study provides the first detailed description of health-related movement behaviours in
patients with COPD before starting their PR. It is novel in its analysis of movement behaviours across
the whole spectrum, from sedentary behaviour to very light, light and moderate intensity PA, including
the pattern of these movements in terms of bout duration. Using cluster analysis, our classification
approach identified subgroups of patients with COPD with notable different PA and sedentary patterns.
4.1. Cluster Differences Regarding PA
Patients with COPD in our study showed markedly different levels of PA before rehabilitation.
MVPA is regarded as decisive for health in previous PA recommendations; for example, the WHO
guidelines [2] recommend at least 150 min of MPA per week. Our three most active clusters (cluster
2, 3 and 4) had average daily MPA volumes of 28, 38 and 70 min, respectively. Thus, about 70% of
all participants with COPD are, according to the guidelines, sufficiently active before rehabilitation
starts. The daily step counts in our study ranged from 2749 (sedentary non-movers), to 5649 (sedentary
occasional movers), to 7866 (sedentary movers), to 11,045 (sedentary exercises). Depew et al. [34]
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reported COPD patients need to achieve >4580 steps per day to avoid severe physical inactivity (SPI),
and later determined that 69% of patients do not reach this cut-off [35]. In our study, only sedentary
non-movers, which includes roughly 30%, remained below this cut-off value. In comparison to other
studies in the rehabilitation context (e.g., Spruit et al. [10]), our sample, and especially the three active
clusters (2,3,4), were considered sufficiently active before PR. When considering the findings of various
reviews reporting low PA levels in people with COPD [10–12], this is a rather surprising result. One
reason for this finding could be the fact that a large proportion of rehabilitants in our study are still
of working age. Rehabilitation was paid for by the German pension insurance for roughly 90% of
all participants. Therefore, most of our COPD patients (75%) were still gainfully employed with an
average age of just 58 years. Our sample differs from many other COPD samples, most of which are
much older and, to a large extent, already retired.
In line with the cluster analysis conducted by Mesquita et al. [14], our study also showed a high
heterogeneity and clear differences in the movement behaviour of people with COPD. Means-based
analysis often suggest that people with COPD are highly physically inactive. Our results confirm
the results of Mesquita et al. [14] that patients with COPD are not physically inactive per se; on the
contrary, there are subgroups that are remarkably active. However, Mesquita et al. [14] described
different movement clusters, including persons with high volume of MVPA but low volume of light
intensity PA; but there are also clusters that behave exactly in opposite directions, i.e., perform a lot of
light activities and little MVPA. This is in contrast to our results. For our four clusters, the duration of
PA in the three different intensity ranges developed in the same direction, indicating that an increase in
one intensity category was also consistently associated with an increase in duration in the other two
intensity categories.
Several current PA guidelines, e.g., the recommendations of the American College of Sports
Medicine [36], those of the WHO [2] or the German PA guidelines [37], recommend that overall MVPA
should be accumulated in bouts of 10 min or longer (e.g., at least 3 × 10 min/day on five days of the
week). By contrast, the current US guidelines [38], for example, do not specify the required minimum
duration of individual bouts. For nine out of 10 patients with COPD in our study, PA bout lengths of at
least 10 min do not occur at all. Van Remoortel et al. [39] previously demonstrated that when PA data
is analysed using these bout cut-points, reported MVPA among individuals with COPD is three to
12-fold lower [39]. This observation also applies to our study where longer bouts of MVPA (of at least
10 min as per the WHO guidelines) were rarely observed. Low physical capacity, dyspnea and fatigue
make it more difficult to be physically active for longer durations. However, even patients with higher
physical capacity (clusters 3 and 4) displayed few bouts of longer duration > 10 min. Attempting to
perform PA ’as fast as possible’ to alleviate the discomfort caused by PA [11], a lack of motivation and
a lifestyle in which a high proportion of activities of daily living are spread across the day could also
be reasons for shorter bouts of MVPA.
4.2. Cluster Differences Regarding Sedentary Behaviour
To our knowledge, this is the first study in the field of COPD applying an analytical approach which
ensures differentiation between SB (≤ 1.5 MET) and very light forms of PA (1.5 MET < x < 2 MET).
This allows a precise analysis of total SB and a distinction from standing. Importantly, all four clusters
display a considerable long sedentary time per day (7.5–10.75 h). For this reason, all four cluster
designations begin with sedentary. Regardless of PA level or GOLD stage, people with COPD spend
a large part of the day in SB before PR. This sedentary time is comparable to SB in other clinical
populations, e.g., people with stroke (10.9 h/day) [40], type-2 diabetes (8.0 h/day) [41], multiple sclerosis
(8.0 h/day) [42] or coronary artery disease (8,0 h/day) [43].
Long periods of sitting, the most prevalent of SB, is particularly harmful to health if the persons
are not also considerably physically active. Ekelund et al. [7] demonstrated in their meta-analysis,
including data from more than one million individuals from the general population, that long sitting
time is associated with increased risk of mortality. The effect is more pronounced in the more inactive
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and only high levels of PA (60–75 min of MVPA) seem to eliminate the increased mortality risk.
In patients with COPD, objectively measured SB has a prognostic value; Furlanetto et al. [8] previously
calculated that individuals with COPD who spent >8.5 h/day in SB had a fourfold increased mortality
risk compared to the less sedentary group. In our study, 70% of all participants show an average
daily sedentary time of more than 8.5 h and even the most active cluster 4 exhibited an average daily
sedentary time of nearly 7.5 h (445 min). Importantly, the sedentary non-movers have an average
sedentary time of 10.75 h (644 min).
In addition to the average duration, it is worth considering the manner in which sedentary time
is accumulated. Uninterrupted sedentary bouts seem to be particularly deleterious for health [44].
Breaking up prolonged sitting, with moderate intense PA (walking) or even with very light intense
PA (e.g., standing) is beneficial to health and leads, among other things, to reduced postprandial
glucose and insulin responses [45]. Our bout analyses showed that there are significant differences
in the accumulation of sedentary time between the clusters. While the sedentary non-movers and
the sedentary occasional movers accumulate their high sedentary time over fewer longer individual
bouts, the more active sedentary movers and the sedentary exercisers interrupt their long daily
sedentary time more frequently. Therefore, it can be assumed that the more active clusters are more
successful in temporally interrupting their very long sedentary periods, which may further enhance
the health-related gap between the clusters.
4.3. Cluster Differences Regarding Clinical and Sociodemographic Parameters
The four clusters showed no statistically significant differences regarding body weight, distribution
of men and women. Gold severity classification (1–4) differed in the clusters with higher disease
severities in the less active clusters but the A–D Gold classification did not differ between clusters.
The number of comorbidities also does not differ significantly between the clusters. However,
differences between the four clusters with regard to disease severity, functional capacity, lung function,
and impact of the disease are significant. The following relationship applies to all clusters. On average,
if one cluster is compared with the slightly less active cluster (e.g., cluster 1 with cluster 2), the more
active cluster shows better functional capacity (six-minute walking test), better lung function (FEV1)
and better quality of life (CAT). The differences between the most active and least active cluster are
large; six-minute walking test: 503 m vs. 377 m; FEV1: 65% vs. 43%; CAT: 20.6 vs. 26.7. Looking at the
CAT scores, mean scores >20 for all four clusters indicate high level of symptom burden across all four
clusters [46–48]. Due to the cross-sectional design, however, we cannot make any statements about
causal relationships. It remains unclear whether lower PA levels are the cause of disease progression
and poor lung function; or vice versa with deteriorations of the disease leading to low PA. The
two variables probably influence each other, as the “dyspnea-inactivity vicious circle” modelled by
Ramon et al. [49] shows.
4.4. Implications for Pulmonary Rehabilitation
This study has some important implications for PR programs. First, it underlines that promoting
PA must be considered a central goal of PR [3]. Based on our results, promoting a minimum amount
of PA does not seem to be equally important for all participants. For the sedentary non-movers
promoting quantity of PA remains indeed a key objective. The other three clusters, corresponding to
70% of the sample, largely meet the current PA guidelines regarding the quantity of PA. Nevertheless,
in addition to the quantity of PA, qualitative aspects of PA participation experiences are also important
for the health effect of PA [50]. Qualitative aspects of PA include, for example, whether PA also
increases psychological well-being. Another qualitative aspect of PA can be whether the activity is
suitable to contribute to coping with the disease. Certain activities can help people with a chronic
condition to distract themselves from the stress of their illness or help people to perceive themselves
as “normal” or able to perform despite their condition. For persons meeting the quantity of PA
guidelines, rehabilitation should concentrate on the promotion or enhancement of qualitative aspects
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of PA. Second, for the sedentary non-movers, which are characterised by low fitness, decreased lung
function and low PA levels, the current recommendations targeting at least 150 min of weekly MPA,
may be overstretching for many [51]. Moy et al. [52] reported that any amount of time spent in MVPA
after a hospital stay was associated with reduced risk of mortality among COPD patients. Thus,
each additional increase in PA away from inactivity is significant, and important health effects may
be experienced even at low levels of activity [53]. The goal of rehabilitation with regard to the PA
promotion should be carefully defined here, preferably together with the patient. A good idea is the
phased approach proposed by Blondeel et al. [54], which first achieves an improvement in physical
performance with an exercise intervention and then thinks about behavioural changes in the next step.
PR programs often fail to achieve sustained and significant increases in PA [55,56]. Individualised,
tailored exercise programs enhance the adherence to PA [36]. For patients with COPD this tailoring
must take into account the significant differences in movement behaviour, and associated with this the
large differences in fitness and lung function.
Considering the high sedentary time of most patients with COPD, it is vitally important that
reducing SB plays a larger role during PR and treatment of the disease. For all clusters, reducing
sitting time and interrupting long periods of sitting emerges as an important goal. For inactive adults,
the meta-analysis from Ekelund et al. [7] suggests that replacing sitting time with light-intensity
PA reduces the risk of all-cause mortality. In addition to reducing the volume of SB, preliminary
evidence suggests that breaking up prolonged periods of SB with light PA may have positive health
effects amongst physically inactive individuals [57]. These conclusions support the statements by
Hill et al. [44] who emphasised that SB can be substantially replaced by light PA, thus leading to an
overall increase in PA. Increases in light PA include activities of daily living such as going shopping
on foot or working in the garden, and represent a more realistic approach to increasing PA in this
population. Indeed, the idea that focusing on reducing SB and, therefore, increasing light PA may be
more achievable and feasible than increasing MVPA levels is well-supported [12,58]. Clinical COPD
guidelines, however, have so far hardly reflected the topic of SB [59]. In the future development of
guidelines and PR programs, the topic of reducing SB time should play a greater role. Thus, the “move
more and sit less” public health strategy could equally target adults with and without COPD.
4.5. Future Research
Our study used a classification approach on the cross-sectional baseline data set of the STAR
study. The STAR study also collects PA and SB six weeks and six months after PR. Further classification
approaches to this longitudinal data (e.g., Linking of Clusters after Removal of a Residude-analysis;
LICUR) will show how the clusters analysed here change their PA and SB after PR. Such analysis,
in combination with the measurement of psychological and physical determinants of PA behaviour, will
enhance our understanding of patients with COPD movement behaviour and its changes over time.
Basic research should focus further on SB bouts and breaks, and their impact on health in this
population. Future applied research should focus on reducing overall time in sedentary behaviour,
breaking up long periods of sedentary behaviour, and in increasing PA in light intensity activities.
4.6. Limitations
Despite this novel data providing relevant and important insight into PA and SB behaviours in
individuals with COPD, some limitations must be discussed. Firstly, although the use of accelerometers
has become the scientific standard and this study followed recent data collection and processing
recommendations from Byrom et al. [20], it must be noted that there remain limitations to accelerometry:
Water-based PA (e.g., swimming or water aerobics) cannot be measured; a valid daily wear time of at
least ten hours does not cover the entire 24 h day; this method under-detects non-ambulatory PA (e.g.,
strength exercise of the upper limbs on a stationary device). Secondly, influences of daylight [60] and
meteorological factors [61] have not yet been taken into account in the analyses. Thirdly, only 418 from
797 individuals were willing to participate in this study. It may be that those who participated were
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more active and motivated with a greater interest in PA than those who refused to participate, which
created a selection bias by overestimating the activity levels of the entire sample. Finally, results of this
study came from a single clinic and country which may limit the international generalizability of the
present findings [62].
5. Conclusions
A key contribution of this study is the detailed reporting of health-related movement behaviours
in individuals with COPD including SB and PA in very light, light and moderate intensity areas as
well as patterns of activity bouts. The present study concludes that patients with COPD perform
varied levels of PA in free-living conditions. However, most patients suffering from COPD spend a
considerable and unhealthy proportion of their daily lives in SB. Consequently, PR programs should
not only aim at the promotion of PA [3] but also consider the reduction of SB as a valuable goal.
Our study proves that cluster analysis of accelerometer data on PA and SB has the potential to
identify subgroups of COPD patients with distinct health-related movement patterns. This more
comprehensive approach of analysing PA data provides a better understanding of movement behaviours
in patients with COPD. Finally, the findings of this study may enable future researchers and clinicians
to better plan and individualise PA promotion and SB reduction interventions for COPD populations.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/8/9/1346/
s1, Supplementary Table S1. The potential accelerometer indicators as a basis for the cluster identification,
Supplementary Figure S1. Scree plot for the identification of the number of clusters.
Author Contributions: W.G., J.C., S.C., K.S. and K.P. conceptualized this study. J.C. and W.G. conducted the
statistical analysis. W.G., K.S. and K.P. have applied for the funding. W.G., J.C. and S.C. wrote the first draft of this
paper. All authors contributed substantially to the final draft of the paper and its revisions. All authors have read
and approved the final manuscript.
Funding: This study is funded by the German Pension Insurance, Section Bavaria South (Deutsche
Rentenversicherung Bayern Süd; Abteilung Rehabilitation und Sozialmedizin, Am Alten Viehmarkt 2, 84028
Landshut, Germany) (reference number: 5.011-6.031.115) (www.deutscherentenversicherung-bayernsued.de),
which was not involved in the design of the study and the collection, management, analysis, interpretation of data,
in writing the manuscript, or the decision to submit the report for publication.
Acknowledgments: The authors thank the German Pension Insurance, Section Bavaria South (Deutsche
Rentenversicherung Bayern Süd), which sponsors and supports this study. We thank study nurses Stephanie
Häusl, Andrea Klotz, Maike Messerschmidt, Berta Obermaier and the recruiting physicians of the Bad Reichenhall
Clinic for their outstanding engagement. We would like to thank Lorena Miranda, Samuel Tonne and Anna Ryan
for their support implementing the study as student research assistants.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
References
1. Pedersen, B.K.; Saltin, B. Exercise as medicine-evidence for prescribing exercise as therapy in 26 different
chronic diseases. Scand. J. Med. Sci. Sports 2015, 25, 1–72. [CrossRef] [PubMed]
2. World Health Organization. Global Recommendations on Physical Activity for Health; World Health Organization:
Geneva, Switzerland, 2010.
3. Spruit, M.A.; Singh, S.J.; Garvey, C.; ZuWallack, R.; Nici, L.; Rochester, C.; Hill, K.; Holland, A.E.; Lareau, S.C.;
Man, W.D.-C.; et al. An official American Thoracic Society/European Respiratory Society statement: Key
concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013, 188, e13–e64.
[CrossRef] [PubMed]
4. Tremblay, M.S.; Chaput, J.-P.; Adamo, K.B.; Aubert, S.; Barnes, J.D.; Choquette, L.; Duggan, M.; Faulkner, G.;
Goldfield, G.S.; Gray, C.E.; et al. Canadian 24-hour movement guidelines for the early years (0–4 years) An
integration of physical activity, sedentary behaviour, and sleep. BMC Public Health 2017, 17, 874. [CrossRef]
[PubMed]
J. Clin. Med. 2019, 8, 1346 13 of 16
5. Gimeno-Santos, E.; Frei, A.; Steurer-Stey, C.; De Batlle, J.; Rabinovich, R.A.; Raste, Y.; Hopkinson, N.S.;
Polkey, M.I.; Van Remoortel, H.; Troosters, T.; et al. Determinants and outcomes of physical activity in
patients with COPD: A systematic review. Thorax 2014, 69, 731–739. [CrossRef] [PubMed]
6. Donaire-Gonzalez, D.; Gimeno-Santos, E.; Balcells, E.; Batlle, d.J.; Ramon, M.A.; Rodriguez, E.; Farrero, E.;
Benet, M.; Guerra, S.; Sauleda, J.; et al. Benefits of physical activity on COPD hospitalisation depend on
intensity. Eur. Respir. J. 2015, 46, 1281–1289. [CrossRef] [PubMed]
7. Ekelund, U.; Steene-Johannessen, J.; Brown, W.J.; Fagerland, M.W.; Owen, N.; Powell, K.E.; Bauman, A.;
Lee, I.-M. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with
mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet 2016,
388, 1302–1310. [CrossRef]
8. Furlanetto, K.C.; Donária, L.; Schneider, L.P.; Lopes, J.R.; Ribeiro, M.; Fernandes, K.B.; Hernandes, N.A.;
Pitta, F. Sedentary behavior is an independent predictor of mortality in subjects with COPD. Respir. Care
2017, 62, 579–587. [CrossRef]
9. Dogra, S.; Good, J.; Buman, M.P.; Gardiner, P.A.; Copeland, J.L.; Stickland, M.K. Physical activity and
sedentary time are related to clinically relevant health outcomes among adults with obstructive lung disease.
BMC Pulm. Med. 2018, 18, 98. [CrossRef]
10. Spruit, M.A.; Pitta, F.; McAuley, E.; Zuwallack, R.L.; Nici, L. Pulmonary rehabilitation and physical activity
in patients with COPD. Am. J. Respir. Crit. Care Med. 2015, 192, 924–933. [CrossRef]
11. Vorrink, S.N.W.; Kort, H.S.M.; Troosters, T.; Lammers, J.-W.J. Level of daily physical activity in individuals
with COPD compared with healthy controls. Respir. Res. 2011, 12, 33. [CrossRef]
12. Mantoani, L.C.; Rubio, N.; McKinstry, B.; MacNee, W.; Rabinovich, R.A. Interventions to modify physical
activity in patients with COPD: A systematic review. Eur. Respir. J. 2016, 48, 69–81. [CrossRef] [PubMed]
13. Evenson, K.R.; Herring, A.H.; Wen, F. Accelerometry-assessed latent class patterns of physical activity and
sedentary behavior with mortality. Am. J. Prev. Med. 2017, 52, 135–143. [CrossRef] [PubMed]
14. Mesquita, R.; Spina, G.; Pitta, F.; Donaire-Gonzalez, D.; Deering, B.M.; Patel, M.S.; Mitchell, K.E.; Alison, J.;
Van Gestel, A.J.R.; Zogg, S.; et al. Physical activity patterns and clusters in 1001 patients with COPD.
Chronic Respir. Dis. 2017, 2, 147997231668720. [CrossRef] [PubMed]
15. Geidl, W.; Semrau, J.; Streber, R.; Lehbert, N.; Wingart, S.; Tallner, A.; Wittmann, M.; Wagner, R.; Schultz, K.;
Pfeifer, K. Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during
inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: Study
protocol for a randomized controlled trial. Trials 2017, 18, 396. [CrossRef] [PubMed]
16. Ozemek, C.; Kirschner, M.M.; Wilkerson, B.S.; Byun, W.; Kaminsky, L.A. Intermonitor reliability of the GT3X
+ accelerometer at hip, wrist and ankle sites during activities of daily living. Physiol. Meas. 2014, 35, 129–138.
[CrossRef] [PubMed]
17. Aadland, E.; Ylvisåker, E.; López Lluch, G. Reliability of the actigraph GT3X + accelerometer in adults under
free-living conditions. PLoS ONE 2015, 10, e0134606. [CrossRef]
18. Rabinovich, R.A.; Louvaris, Z.; Raste, Y.; Langer, D.; Van Remoortel, H.; Giavedoni, S.; Burtin, C.;
Regueiro, E.M.G.; Vogiatzis, I.; Hopkinson, N.S.; et al. Validity of physical activity monitors during
daily life in patients with COPD. Eur. Respir. J. 2013, 42, 1205–1215. [CrossRef]
19. Van Remoortel, H.; Raste, Y.; Louvaris, Z.; Giavedoni, S.; Burtin, C.; Langer, D.; Wilson, F.; Rabinovich, R.;
Vogiatzis, I.; Hopkinson, N.S.; et al. Validity of six activity monitors in chronic obstructive pulmonary
disease: A comparison with indirect calorimetry. PLoS ONE 2012, 7, e39198. [CrossRef]
20. Byrom, B.; Rowe, D.A. Measuring free-living physical activity in COPD patients: Deriving methodology
standards for clinical trials through a review of research studies. Contemp. Clin. Trials 2016, 47, 172–184.
[CrossRef]
21. Jones, P.W.; Harding, G.; Berry, P.; Wiklund, I.; Chen, W.-H.; Kline Leidy, N. Development and first validation
of the COPD Assessment Test. Eur. Respir. J. 2009, 34, 648–654. [CrossRef]
22. Holland, A.E.; Spruit, M.A.; Troosters, T.; Puhan, M.A.; Pepin, V.; Saey, D.; McCormack, M.C.; Carlin, B.W.;
Sciurba, F.C.; Pitta, F.; et al. An official European Respiratory Society/American Thoracic Society technical
standard: Field walking tests in chronic respiratory disease. Eur. Respir. J. 2014, 44, 1428–1446. [CrossRef]
[PubMed]
J. Clin. Med. 2019, 8, 1346 14 of 16
23. Vogelmeier, C.F.; Criner, G.J.; Martinez, F.J.; Anzueto, A.; Barnes, P.J.; Bourbeau, J.; Celli, B.R.; Chen, R.;
Decramer, M.; Fabbri, L.M.; et al. Global strategy for the diagnosis, management, and prevention of chronic
obstructive lung disease 2017 report GOLD executive summary. Am. J. Respir. Crit. Care Med. 2017, 49.
[CrossRef]
24. Vestbo, J.; Hurd, S.S.; Agustí, A.G.; Jones, P.W.; Vogelmeier, C.; Anzueto, A.; Barnes, P.J.; Fabbri, L.M.;
Martinez, F.J.; Nishimura, M.; et al. Global strategy for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013, 187, 347–365.
[CrossRef] [PubMed]
25. Freedson, P.S.; Melanson, E.; Sirard, J. Calibration of the computer science and applications, inc. accelerometer.
Med. Sci. Sports Exerc. 1998, 30, 777–781. [CrossRef] [PubMed]
26. Gorman, E.; Hanson, H.M.; Yang, P.H.; Khan, K.M.; Liu-Ambrose, T.; Ashe, M.C. Accelerometry analysis of
physical activity and sedentary behavior in older adults: A systematic review and data analysis. Eur. Rev.
Aging Phys. Act. 2014, 11, 35–49. [CrossRef] [PubMed]
27. Cain, K.L.; Geremia, C.M. Accelerometer Data Collection and Scoring Manual for Adult & Senior Studies; San
Diego State University: San Diego, CA, USA, 2012; Available online: http://sallis.ucsd.edu/measures.html
(accessed on 12 March 2018).
28. Backhaus, K.; Erichson, B.; Plinke, W.; Weiber, R. Clusteranalyse. In Multivariate Analysemethoden: Eine
Anwendungsorientierte Einführung; Backhaus, K., Erichson, B., Plinke, W., Weiber, R., Eds.; Springer: Berlin,
Germany, 2016; ISBN 978-3-662-46075-7.
29. Milligan, G.W.; Cooper, M.C. An Examination of Procedures for Determining the Number of Clusters in a
Data Set. Psychometrika 1985, 50, 159–179. [CrossRef]
30. Calinski, R.B.; Harabasz, J. A dendrite method for cluster analysis. Commun. Stat. 1974, 3, 1–27.
31. Duda, R.O.; Hart, P.E. Pattern Classification and Scene Analysis; Wiley: New York, NY, USA, 1973;
ISBN 978-0471223610.
32. McVeigh, J.A.; Winkler, E.A.H.; Howie, E.K.; Tremblay, M.S.; Smith, A.; Abbott, R.A.; Eastwood, P.R.;
Healy, G.N.; Straker, L.M. Objectively measured patterns of sedentary time and physical activity in young
adults of the Raine study cohort. Int. J. Behav. Nutr. Phys. Act. 2016, 13, 41. [CrossRef]
33. Charrad, M.; Ghazzali, N.; Boiteau, V.; Niknafs, A. NbClust: An R package for determining the relevant
number of clusters in a data set. J. Stat. Softw. 2014, 61. [CrossRef]
34. Depew, Z.S.; Novotny, P.J.; Benzo, R.P. How many steps are enough to avoid severe physical inactivity in
patients with chronic obstructive pulmonary disease? Respirology 2012, 17, 1026–1027. [CrossRef]
35. Depew, Z.S.; Garofoli, A.C.; Novotny, P.J.; Benzo, R.P. Screening for severe physical inactivity in chronic
obstructive pulmonary disease: The value of simple measures and the validation of two physical activity
questionnaires. Chronic Respir. Dis. 2013, 10, 19–27. [CrossRef] [PubMed]
36. Garber, C.E.; Blissmer, B.; Deschenes, M.R.; Franklin, B.A.; LAMONTE, M.J.; Lee, I.-M.; Nieman, D.C.;
Swain, D.P. American College of Sports Medicine position stand. Quantity and quality of exercise for
developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently
healthy adults Guidance for prescribing exercise. Med. Sci. Sports Exerc. 2011, 43, 1334–1359. [CrossRef]
[PubMed]
37. Pfeifer, K.; Rütten, A. National Recommendations for Physical Activity and Physical Activity Promotion; FAU
University Press: Erlangen, Germany, 2016.
38. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd ed.;
Department of Health and Human Services: Washington, DC, USA, 2018.
39. Van Remoortel, H.; Camillo, C.A.; Langer, D.; Hornikx, M.; Demeyer, H.; Burtin, C.; Decramer, M.;
Gosselink, R.; Janssens, W.; Troosters, T.; et al. Moderate intense physical activity depends on selected
metabolic equivalent of task (MET) cut-off and type of data analysis. PLoS ONE 2013, 8, e84365. [CrossRef]
[PubMed]
40. English, C.; Healy, G.N.; Coates, A.; Lewis, L.; Olds, T.; Bernhardt, J. Sitting and activity time in people with
stroke. Phys. Ther. 2016, 96, 193–201. [CrossRef] [PubMed]
J. Clin. Med. 2019, 8, 1346 15 of 16
41. Cooper, A.R.; Sebire, S.; Montgomery, A.A.; Peters, T.J.; Sharp, D.J.; Jackson, N.; Fitzsimons, K.; Dayan, C.M.;
Andrews, R.C. Sedentary time, breaks in sedentary time and metabolic variables in people with newly
diagnosed type 2 diabetes. Diabetologia 2012, 55, 589–599. [CrossRef] [PubMed]
42. Sasaki, J.E.; Hickey, A.; Staudenmayer, J.; John, D.; Kent, J.A.; Freedson, P.S. Performance of activity
classification algorithms in free-living older adults. Med. Sci. Sports Exerc. 2016, 48, 941–950. [CrossRef]
43. Prince, S.A.; Blanchard, C.M.; Grace, S.L.; Reid, R.D. Objectively-measured sedentary time and its association
with markers of cardiometabolic health and fitness among cardiac rehabilitation graduates. Eur. J.
Prev. Cardiol. 2016, 23, 818–825. [CrossRef]
44. Hill, K.; Gardiner, P.A.; Cavalheri, V.; Jenkins, S.C.; Healy, G.N. Physical activity and sedentary behaviour:
Applying lessons to chronic obstructive pulmonary disease. Intern. Med. J. 2015, 45, 474–482. [CrossRef]
45. Dunstan, D.W.; Kingwell, B.A.; Larsen, R.; Healy, G.N.; Cerin, E.; Hamilton, M.T.; Shaw, J.E.; Bertovic, D.A.;
Zimmet, P.Z.; Salmon, J.; et al. Breaking up prolonged sitting reduces postprandial glucose and insulin
responses. Diabetes Care 2012, 35, 976–983. [CrossRef]
46. O’Donnell, D.; Gebke, K. Activity restriction in mild COPD: A challenging clinical problem. COPD 2014,
9, 577–588. [CrossRef]
47. Silva Junior, J.L.; Conde, M.B.; De Sousa Correa, K.; Da Silva, C.; Da Silva Prestes, L.; Rabahi, M.F. COPD
Assessment Test (CAT) score as a predictor of major depression among subjects with chronic obstructive
pulmonary disease and mild hypoxemia: A case-control study. BMC Pulm. Med. 2014, 14, 186. [CrossRef]
[PubMed]
48. Ghobadi, H.; Ahari, S.S.; Kameli, A.; Lari, S.M. The Relationship between COPD Assessment Test (CAT)
Scores and Severity of Airflow Obstruction in Stable COPD Patients. Tanaffos 2012, 11, 22–26. [PubMed]
49. Ramon, M.A.; Ter Riet, G.; Carsin, A.-E.; Gimeno-Santos, E.; Agustí, A.; Antó, J.M.; Donaire-Gonzalez, D.;
Ferrer, J.; Rodríguez, E.; Rodriguez-Roisin, R.; et al. The dyspnoea-inactivity vicious circle in COPD:
Development and external validation of a conceptual model. Eur. Respir. J. 2018, 52. [CrossRef] [PubMed]
50. Shirazipour, C.H.; Evans, M.B.; Leo, J.; Lithopoulos, A.; Martin Ginis, K.A.; Latimer-Cheung, A.E. Program
conditions that foster quality physical activity participation experiences for people with a physical disability
A systematic review. Disabil. Rehabilit. 2018. [CrossRef] [PubMed]
51. Arena, R.; McNeil, A.; Street, S.; Bond, S.; Laddu, D.R.; Lavie, C.J.; Hills, A.P. Let us talk about moving:
Reframing the exercise and physical activity discussion. Curr. Probl. Cardiol. 2018, 43, 154–179. [CrossRef]
[PubMed]
52. Moy, M.L.; Gould, M.K.; Liu, I.-L.A.; Lee, J.S.; Nguyen, H.Q. Physical activity assessed in routine care predicts
mortality after a COPD hospitalisation. ERJ Open Res. 2016, 2. [CrossRef] [PubMed]
53. Warburton, D.E.R.; Bredin, S.S.D. Reflections on Physical Activity and Health: What Should We Recommend?
Can. J. Cardiol. 2016, 32, 495–504. [CrossRef] [PubMed]
54. Blondeel, A.; Demeyer, H.; Janssens, W.; Troosters, T. The role of physical activity in the context of pulmonary
rehabilitation. COPD 2019. [CrossRef]
55. Burge, A.T.; Cox, N.S.; Abramson, M.J.; Holland, A.E. Interventions for promoting physical activity in people
with COPD. Cochrane Database Syst. Rev. 2017, 5, 20415. [CrossRef]
56. Shioya, T.; Sato, S.; Iwakura, M.; Takahashi, H.; Terui, Y.; Uemura, S.; Satake, M. Improvement of physical
activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment.
Respir. Investig. 2018, 56, 292–306. [CrossRef]
57. Benatti, F.B.; Ried-Larsen, M. The Effects of Breaking up Prolonged Sitting Time: A Review of Experimental
Studies. Med. Sci. Sports Exerc. 2015, 47, 2053–2061. [CrossRef] [PubMed]
58. Cavalheri, V.; Straker, L.; Gucciardi, D.F.; Gardiner, P.A.; Hill, K. Changing physical activity and sedentary
behaviour in people with COPD. Respirology 2016, 21, 419–426. [CrossRef] [PubMed]
59. Lewthwaite, H.; Effing, T.W.; Olds, T.; Williams, M.T. Physical activity, sedentary behaviour and sleep in
COPD guidelines: A systematic review. Chronic Respir. Dis. 2017, 14, 231–244. [CrossRef] [PubMed]
60. Demeyer, H.; Burtin, C.; Van Remoortel, H.; Hornikx, M.; Langer, D.; Decramer, M.; Gosselink, R.; Janssens, W.;
Troosters, T. Standardizing the analysis of physical activity in patients with COPD following a pulmonary
rehabilitation program. Chest 2014, 146, 318–327. [CrossRef] [PubMed]
J. Clin. Med. 2019, 8, 1346 16 of 16
61. Alahmari, A.D.; Mackay, A.J.; Patel, A.R.C.; Kowlessar, B.S.; Singh, R.; Brill, S.E.; Allinson, J.P.; Wedzicha, J.A.;
Donaldson, G.C. Influence of weather and atmospheric pollution on physical activity in patients with COPD.
Respir. Res. 2015, 16, 786. [CrossRef] [PubMed]
62. Pitta, F.; Breyer, M.-K.; Hernandes, N.A.; Teixeira, D.; Sant’Anna, T.J.P.; Fontana, A.D.; Probst, V.S.;
Brunetto, A.F.; Spruit, M.A.; Wouters, E.F.M.; et al. Comparison of daily physical activity between COPD
patients from Central Europe and South America. Respir. Med. 2009, 103, 421–426. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
